[Not Available].
作者信息
Tzankova Velina, Becker Werner J, Chan Tommy L H
机构信息
Division de neurologie, Département de médecine (Tzankova), Université de Toronto, Toronto, Ont.; Département de neurosciences cliniques et Institut de neurologie Hotchkiss (Becker), Faculté de médecine Cumming, Université de Calgary, Calgary, Alb.; Département de neurologie clinique (Chan), Université Western, London, Ont.
出版信息
CMAJ. 2023 Apr 11;195(14):E524-E530. doi: 10.1503/cmaj.211969-f.
Abstract
摘要
相似文献
1
[Not Available].[无可用内容]
CMAJ. 2023 Apr 11;195(14):E524-E530. doi: 10.1503/cmaj.211969-f.
2
Does the neurobiology of migraine make migraine patients "difficult"?偏头痛的神经生物学因素会使偏头痛患者“难缠”吗？
Headache. 2012 Nov-Dec;52(10):1611. doi: 10.1111/j.1526-4610.2012.02257.x. Epub 2012 Sep 27.
3
The Development of the Pediatric Migraine Action Plan (PedMAP).儿童偏头痛行动计划（PedMAP）的制定。
Headache. 2019 Nov;59(10):1671-1672. doi: 10.1111/head.13666.
4
Rare migraine and migraine equivalents: is migraine a pineal syndrome?罕见偏头痛及偏头痛等效症：偏头痛是一种松果体综合征吗？
Pa Med. 1986 Mar;89(3):57-9.
5
Migraine in Children.儿童偏头痛
Headache. 2017 Jun;57(6):1021-1022. doi: 10.1111/head.13091.
6
[Migraine. Symptoms, diagnosis and drug therapy].[偏头痛。症状、诊断与药物治疗]
Anaesthesist. 1999 Nov;48(11):845-56. doi: 10.1007/s001010050797.
7
Complicated migraine and migraine variants.复杂性偏头痛和偏头痛变异型。
Curr Pain Headache Rep. 2002 Jun;6(3):233-9. doi: 10.1007/s11916-002-0040-7.
8
[Diagnosis and therapy of migraine].[偏头痛的诊断与治疗]
Krankenpfl J. 1994 Nov;32(11):450-8.
9
Is migraine a complex regional pain syndrome of the brain? Migraine prophylaxis with vitamin C?偏头痛是大脑的复杂性区域疼痛综合征吗？用维生素C预防偏头痛？
Pain Pract. 2011 Mar-Apr;11(2):199-200. doi: 10.1111/j.1533-2500.2011.00442.x.
10
[Diagnosis and therapies of refractory migraine].[难治性偏头痛的诊断与治疗]
Rinsho Shinkeigaku. 2011 Nov;51(11):877-80. doi: 10.5692/clinicalneurol.51.877.
本文引用的文献
1
Pharmacologic prevention of migraine.偏头痛的药物预防
CMAJ. 2023 Feb 6;195(5):E187-E192. doi: 10.1503/cmaj.221607.
2
Comparison of New Pharmacologic Agents With Triptans for Treatment of Migraine: A Systematic Review and Meta-analysis.新型药物与曲普坦类药物治疗偏头痛的比较：系统评价和荟萃分析。
JAMA Netw Open. 2021 Oct 1;4(10):e2128544. doi: 10.1001/jamanetworkopen.2021.28544.
3
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice.美国头痛学会共识声明：更新将新的偏头痛治疗方法整合到临床实践中的建议。
Headache. 2021 Jul;61(7):1021-1039. doi: 10.1111/head.14153. Epub 2021 Jun 23.
4
Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial.口服rimegepant 用于偏头痛的预防性治疗：一项 2/3 期、随机、双盲、安慰剂对照试验。
Lancet. 2021 Jan 2;397(10268):51-60. doi: 10.1016/S0140-6736(20)32544-7. Epub 2020 Dec 15.
5
Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019.偏头痛仍是全球致残原因中的第二位，在年轻女性中则位居首位：全球疾病负担研究2019的结果。
J Headache Pain. 2020 Dec 2;21(1):137. doi: 10.1186/s10194-020-01208-0.
6
Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52-Week Extension Trial.乌布列彭特用于偏头痛急性治疗的长期安全性评价：第 3 阶段，随机，52 周扩展试验。
Headache. 2020 Jan;60(1):141-152. doi: 10.1111/head.13682.
7
Neuroimaging for Migraine: The American Headache Society Systematic Review and Evidence-Based Guideline.偏头痛的神经影像学：美国头痛学会系统评价和循证指南。
Headache. 2020 Feb;60(2):318-336. doi: 10.1111/head.13720. Epub 2019 Dec 31.
8
Ubrogepant for the Treatment of Migraine.乌布罗苷肽治疗偏头痛。
N Engl J Med. 2019 Dec 5;381(23):2230-2241. doi: 10.1056/NEJMoa1813049.
9
Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial.Ubrogepant 与安慰剂在偏头痛急性治疗中对疼痛及最困扰相关症状的影响：ACHIEVE II 随机临床试验。
JAMA. 2019 Nov 19;322(19):1887-1898. doi: 10.1001/jama.2019.16711.
10
ACR Appropriateness Criteria® Headache.ACR 适宜性标准®头痛。
J Am Coll Radiol. 2019 Nov;16(11S):S364-S377. doi: 10.1016/j.jacr.2019.05.030.
Zotero 插件